Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $113,438 (100.0% shares, 0.0% debt)

Holdings (6)

BVS BIOVENTUS 37.9%

Value ($000) $42,970 Shares 13,021,324 Est. Cost $13.37 Unrealized -73.8%

TELA TELA BIO, INC. 29.0%

Value ($000) $32,886 Shares 4,110,709 Est. Cost $11.82 Unrealized -21.3%

EYPT EYEPOINT PHARMACEUTICALS INC 24.6%

Value ($000) $27,892 Shares 3,490,921 Est. Cost $4.68 Unrealized +134.3%

— REVANCE THERAPEUTICS INC 4.6%

Value ($000) $5,243 Shares 457,085 Est. Cost $31.50 Unrealized —

MNOV MEDICINOVA INC 2.0%

Value ($000) $2,311 Shares 1,105,941 Est. Cost $2.95 Unrealized -21.1%

— VENUS CONCEPT, INC. 1.9%

Value ($000) $2,135 Shares 1,089,195 Est. Cost $2.12 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BVS	BIOVENTUS	13,021,324	$42,970	37.9%	$13.37	-73.8%	COM CL A	09075A108
TELA	TELA BIO, INC.	4,110,709	$32,886	29.0%	$11.82	-21.3%	COM	872381108
EYPT	EYEPOINT PHARMACEUTICALS INC	3,490,921	$27,892	24.6%	$4.68	+134.3%	COM NEW	30233G209
—	REVANCE THERAPEUTICS INC	457,085	$5,243	4.6%	$31.50	—	COM	761330109
MNOV	MEDICINOVA INC	1,105,941	$2,311	2.0%	$2.95	-21.1%	COM NEW	58468P206
—	VENUS CONCEPT, INC.	1,089,195	$2,135	1.9%	$2.12	—	COM	92332W105